uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Everolimus Plus Octreotide Long-Acting Repeatable (LAR) for the Treatment of Advanced Neuroendocrine Tumors (NET) Associated with Carcinoid Syndrome: Updated Overall Survival Results from RADIANT-2 Study
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences.
Show others and affiliations
2014 (English)In: Pancreas, ISSN 0885-3177, E-ISSN 1536-4828, Vol. 43, no 3, 508-509 p.Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
2014. Vol. 43, no 3, 508-509 p.
National Category
Gastroenterology and Hepatology
URN: urn:nbn:se:uu:diva-228361ISI: 000333166800085OAI: oai:DiVA.org:uu-228361DiVA: diva2:734047
6th Annual Meeting of the North American NeuroEndocrine Tumor Society, October 4–5, 2013, Charleston, South Carolina
Available from: 2014-07-14 Created: 2014-07-11 Last updated: 2014-07-14Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Öberg, Kjell E.
By organisation
Department of Medical Sciences
In the same journal
Gastroenterology and Hepatology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 160 hits
ReferencesLink to record
Permanent link

Direct link